The use of dexrazoxane for the prevention of anthracycline extravasation injury

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.2, 2008-02, pp. : 217-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dexrazoxane for the Prevention of Cardiac Toxicity and Treatment of Extravasation Injury from the Anthracycline Antibiotics

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 10, 2012-08 ,pp. : 1949-1956

Bentham Science Publishers

Access to resources Recommend Favorite

Dexrazoxane: A Review of its Use for Cardioprotection During Anthracycline Chemotherapy

By Cvetkovi

Drugs, Vol. 65, Iss. 7, 2005-01 ,pp. : 1005-1024

Adis International

Access to resources Recommend Favorite

Dexrazoxane: A Review of its Use as a Cardioprotective Agent in Patients Receiving Anthracycline-Based Chemotherapy

By Wiseman L.R. Spencer C.M.

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 385-403

Adis International

Access to resources Recommend Favorite

Doxorubicin: Extravasation treated with dexrazoxane: case report

Reactions Weekly, Vol. 1, Iss. 1318, 2010-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Epirubicin: Extravasation in an elderly patient treated with dexrazoxane: case report

Reactions Weekly, Vol. 1, Iss. 1347, 2011-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite